Sanara MedTech Inc (SMTI)

33.51 -0.69 (-2.02%) USD  |  NASDAQ  |  Dec 27, 09:36
More

Sanara MedTech Research and Development Expense (Quarterly): 1.360M for Sept. 30, 2024

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for SMTI.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
AptarGroup Inc --
Daxor Corp --
Precision Optics Corp Inc 0.4007M
Warby Parker Inc --
Perspective Therapeutics Inc 12.03M